METROPOLIS - Technical Analysis with Chart Patterns & Indicators

Last Updated Time : 05 Nov 25, 7:43 am

Html

Copy

Technical Rating: 3.6

Technical Analysis Summary

• Trend: Reversing from highs, showing short-term weakness
• Moving Averages: Price (₹1,976) is below DMA 50 (₹2,002) but above DMA 200 (₹1,922), indicating mild bearish pressure
• RSI (45.9): Neutral zone, leaning toward weakness
• MACD (-31.4): Bearish crossover, confirming downward momentum
• Bollinger Bands: Price near mid-band, suggesting consolidation with downside bias
• Volume: Below average (37.8K vs 72.9K), indicating weak participation

Entry & Exit Zones

• Support: ₹1,920 – ₹1,950 (near DMA 200 and recent base)
• Resistance: ₹2,000 – ₹2,030 (DMA 50 and prior swing highs)
• Optimal Entry: ₹1,940 – ₹1,960 if RSI stabilizes and MACD flattens
• Exit Zone: ₹2,000 – ₹2,030 if price struggles near resistance

Positive

• Quarterly PAT growth from ₹23.8 Cr. to ₹35.6 Cr.
• EPS of ₹25.1 and decent ROCE (13.4%)
• Positive DII sentiment (+0.70%)
• Price up 69.7% over 52 weeks

Limitation

• High P/E of 79.3 vs industry average of 37.4
• Negative PEG ratio (-5.67) suggests valuation concerns
• MACD and RSI indicate bearish momentum
• Decline in FII holding (-0.31%)

Company Negative News

• Concerns over high valuation and competitive pressure in diagnostics sector

Company Positive News

• Expansion in Tier 2 and Tier 3 cities driving revenue growth
• Improved profitability and operational efficiency in recent quarters

Industry

• METROPOLIS operates in the diagnostics and healthcare services sector
• Peers include Dr. Lal PathLabs, Thyrocare, and Vijaya Diagnostic

Conclusion

METROPOLIS is currently reversing from its highs with bearish technical indicators and weak momentum. While fundamentals show improvement, valuation concerns and low volume suggest caution. Traders may consider entry near ₹1,940 with targets around ₹2,030, watching for MACD and RSI recovery.